We are live on
!
Find out more
ARC
Absolute Return Capital Portfolio holdings
AUM
$1.57B
1-Year Est. Return
6.36%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
-6.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.1B
AUM Growth
+$1.89B
(+26%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
12.63%
Holding
786
New
160
Increased
244
Reduced
271
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$145M |
| 2 |
Procter & Gamble
PG
|
+$121M |
| 3 |
Chevron
CVX
|
+$104M |
| 4 |
Apple
AAPL
|
+$95.7M |
| 5 |
Microsoft
MSFT
|
+$74.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$52.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$50.3M |
| 3 |
Pfizer
PFE
|
+$42.9M |
| 4 |
CNX Resources
CNX
|
+$42.5M |
| 5 |
CVS Health
CVS
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.5% |
| 2 | Energy | 14.11% |
| 3 | Healthcare | 12.44% |
| 4 | Technology | 10.58% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
IBM
IBM
$200B
| $44.1M | 0.48% |
245,806
+240,876
| +4,886% | +$41.5M |
|
|
BCR
52
DELISTED
CR Bard Inc.
BCR
| $43.9M | 0.48% |
327,443
+96,929
| +42% | +$12.8M |
|
|
LLL
53
DELISTED
L3 Technologies, Inc.
LLL
| $43.9M | 0.48% |
410,381
+28,192
| +7% | +$2.82M |
|
54
UnitedHealth
UNH
$387B
| $43M | 0.47% |
571,336
-118,665
| -17% | -$8.52M |
|
55
Corning
GLW
$133B
| $43M | 0.47% |
2,414,030
+1,141,613
| +90% | +$18.8M |
|
56
WEC Energy
WEC
$36.9B
| $42.9M | 0.47% |
1,036,975
+33,643
| +3% | +$1.4M |
|
57
AT&T
T
$152B
| $42.3M | 0.47% |
1,593,028
+774,669
| +95% | +$20.4M |
|
|
COL
58
DELISTED
Rockwell Collins
COL
| $40.9M | 0.45% |
553,613
-28,726
| -5% | -$2.04M |
|
|
YHOO
59
DELISTED
Yahoo Inc
YHOO
| $40.9M | 0.45% |
1,010,761
-1,026,580
| -50% | -$36.8M |
|
60
Tenet Healthcare
THC
$16.8B
| $40.1M | 0.44% |
952,948
+660,981
| +226% | +$28.8M |
|
61
Pinnacle West Capital
PNW
$13.1B
| $40M | 0.44% |
755,741
+270,689
| +56% | +$14.8M |
|
62
Cencora
COR
$59.9B
| $40M | 0.44% |
568,677
+69,504
| +14% | +$4.67M |
|
|
CFN
63
DELISTED
CAREFUSION CORPORATION
CFN
| $39.2M | 0.43% |
+984,618
| New | +$38.3M |
|
64
Darden Restaurants
DRI
$22.7B
| $38.3M | 0.42% |
788,494
+63,968
| +9% | +$2.96M |
|
65
United Parcel Service
UPS
$100B
| $37.7M | 0.41% |
+358,715
| New | +$35.3M |
|
66
Coca-Cola
KO
$351B
| $37.4M | 0.41% |
+905,994
| New | +$35.7M |
|
67
Pitney Bowes
PBI
$2.51B
| $37.3M | 0.41% |
1,602,231
-1,187,563
| -43% | -$25.5M |
|
|
SIAL
68
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $37.2M | 0.41% |
396,200
+35,958
| +10% | +$3.12M |
|
69
Goldman Sachs
GS
$314B
| $37.1M | 0.41% |
209,217
+20,653
| +11% | +$3.41M |
|
70
Cigna
CI
$74.5B
| $36.8M | 0.4% |
420,098
+75,614
| +22% | +$6.19M |
|
71
PepsiCo
PEP
$187B
| $36.5M | 0.4% |
+439,524
| New | +$36.5M |
|
72
APA Corp
APA
$12.4B
| $36.4M | 0.4% |
+423,580
| New | +$37.7M |
|
73
Dover
DOV
$28.8B
| $36.2M | 0.4% |
559,381
+100,669
| +22% | +$6.16M |
|
74
Air Products & Chemicals
APD
$65.8B
| $35.7M | 0.39% |
345,528
+49,409
| +17% | +$4.98M |
|
75
Cisco
CSCO
$441B
| $35.7M | 0.39% |
+1,592,788
| New | +$35.2M |
|
Similar funds
OA
MCC
NM
AH
TRV
GHF
CWA
RI
Absolute Return Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Absolute Return Capital held 786 positions worth $9.1B, up 26% from $7.2B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Absolute Return Capital deployed $1.21B of net new capital in Q4 2013, opening 160 new positions and adding to 244 existing holdings. Its largest new stake was Apple: 5,068,168 shares worth $102M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $52.3M trimmed.
- Absolute Return Capital's largest Q4 2013 buy was Apple: 5,068,168 shares worth $102M.
- Absolute Return Capital added most to ExxonMobil in Q4 2013, an estimated $145M increase.
- Absolute Return Capital's biggest Q4 2013 reduction was Amgen, cutting an estimated $52.3M.
- Absolute Return Capital fully exited Johnson & Johnson in Q4 2013, selling an estimated $50.3M.
- Absolute Return Capital's ten largest holdings make up 13% of its $9.1B portfolio in Q4 2013.
- Absolute Return Capital opened 160 new positions and closed 99 in Q4 2013.
- Absolute Return Capital's portfolio value rose 26% quarter-over-quarter to $9.1B.
Based on Absolute Return Capital's 13F filing for Q4 2013, filed 10 Feb 2014.